Iris-Claw Anterior Chamber Phakic Intraocular Lens Explantation: A Case Series

Overview

Journal J Curr Ophthalmol

Date 2024 Sep 16

PMID 39281391

Authors

Sofia Cunha Teixeira

Pedro Martins

Teresa Pacheco

Carlos Arede

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate indications, clinic characteristics, and outcomes in a series of patients who underwent explantation of phakic intraocular lens (pIOL).

Methods: Retrospective case series of patients who underwent iris-claw pIOL explantation in our institution from 2018 to 2022. Indications for explantation and visual and refractive outcomes were analyzed.

Results: Twenty-three eyes of 14 patients underwent pIOL explantation with a mean time to explantation of 11.7 ± 3.4 years. The mean age at explantation was 46.0 ± 3.9 years. Sixteen Artisan and seven Artiflex IOL were explanted. The main indication for explantation was endothelial cell loss ( = 14) and morphometric significant alterations of endothelial cells other than endothelial cell count decline ( = 5). The mean corrected vision after explantation was 0.4 ± 0.4 logMAR, and around 70% of intervened patients achieved visual acuity of at least 0.3 logMAR (0.5 in decimal scale).

Conclusions: In our group series, the main reason for the removal of pIOL was endothelial cell loss. This complication should be monitored and followed, so that early actions, namely IOL explantation, can be performed to avoid the development of deterioration requiring corneal transplantation. In fact, loss of follow-up, found in several cases for many years, continues to be a serious problem.

References

Galvis V, Villamil J, Acuna M, Camacho P, Merayo-Lloves J, Tello A . Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®). Graefes Arch Clin Exp Ophthalmol. 2019; 257(12):2775-2787. DOI: 10.1007/s00417-019-04506-9. View

Feizi S . Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018; 10:2515841418815802. PMC: 6293368. DOI: 10.1177/2515841418815802. View

Moshirfar M, Imbornoni L, Ostler E, Muthappan V . Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens. Clin Ophthalmol. 2014; 8:711-6. PMC: 3986296. DOI: 10.2147/OPTH.S59878. View

Duignan E, Quigley C, Treacy M, Aldouri A, OKeefe M . Iris-fixated phakic intraocular lens explantation. Eur J Ophthalmol. 2020; 31(3):988-993. DOI: 10.1177/1120672120934985. View

Bourne W, Nelson L, Hodge D . Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci. 1997; 38(3):779-82. View

Barsam A, Allan B . Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia. Cochrane Database Syst Rev. 2014; (6):CD007679. PMC: 10726981. DOI: 10.1002/14651858.CD007679.pub4. View

Kohnen T, Kook D, Morral M, Guell J . Phakic intraocular lenses: part 2: results and complications. J Cataract Refract Surg. 2010; 36(12):2168-94. DOI: 10.1016/j.jcrs.2010.10.007. View

Alio J, Abdelrahman A, Javaloy J, Iradier M, Ortuno V . Angle-supported anterior chamber phakic intraocular lens explantation causes and outcome. Ophthalmology. 2006; 113(12):2213-20. DOI: 10.1016/j.ophtha.2006.05.057. View

Chen L, Chang Y, Kuo J, Rajagopal R, Azar D . Metaanalysis of cataract development after phakic intraocular lens surgery. J Cataract Refract Surg. 2008; 34(7):1181-200. DOI: 10.1016/j.jcrs.2008.03.029. View

10.

Martinez L, Tello A, Galvis V, Villamizar S, Nova D . DETERMINATION OF FACTORS ASSOCIATED WITH LONG-TERM ENDOTHELIAL LOSS AND REFRACTIVE RESULT IN PATIENTS WITH ARTISAN PHAKIC LENS. Cesk Slov Oftalmol. 2022; 78(4):188-195. DOI: 10.31348/2022/21. View

11.

Kohnen T, Maxwell A, Holland S, Lane S, Von Tress M, Salem C . Ten-year safety follow-up and post-explant analysis of an anterior chamber phakic IOL. J Cataract Refract Surg. 2020; 46(11):1457-1465. DOI: 10.1097/j.jcrs.0000000000000351. View

12.

Kohnen T, LaFontaine L, Andrew R . Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens. J Cataract Refract Surg. 2017; 43(9):1163-1170. DOI: 10.1016/j.jcrs.2017.06.035. View

13.

Tang Y, Xu J, Chen J, Lu Y . Long-Term Destiny of Corneal Endothelial Cells in Anterior Chamber Intraocular Lens-Implanted Eyes. J Ophthalmol. 2021; 2020:5967509. PMC: 7783513. DOI: 10.1155/2020/5967509. View

14.

Jonker S, Berendschot T, Ronden A, Saelens I, Bauer N, Nuijts R . Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results. Ophthalmology. 2017; 125(4):486-494. DOI: 10.1016/j.ophtha.2017.08.011. View

15.

Jonker S, Van Averbeke A, Berendschot T, Saelens I, Nuijts R . Risk factors for explantation of iris-fixated phakic intraocular lenses. J Cataract Refract Surg. 2019; 45(8):1092-1098. DOI: 10.1016/j.jcrs.2019.03.009. View

16.

Wilson R, Roper-Hall M . Effect of age on the endothelial cell count in the normal eye. Br J Ophthalmol. 1982; 66(8):513-5. PMC: 1039838. DOI: 10.1136/bjo.66.8.513. View